乌尔索二氧化胆酸对心脏代谢风险因素的影响:随机对照试验的系统审查和元分析
Elaheh Rashidbeygi1, Niloufar Rasaei2,3, Mohammad Reza Amini4
1Student Research Committee, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
BMC cardiovascular disorders
|February 21, 2025
概括
乌尔苏多西胆酸 (UDCA) 可能改善体质指数和腹压血压,但会增加心压血压. 这种胆汁酸对减肥或炎症标志物没有显著影响. 建议进行进一步的研究.
科学领域:
- 代谢健康 代谢健康
- 心血管健康 心血管健康
- 胆酸研究 胆酸研究
背景情况:
- 肥胖和高血压等慢性疾病是全球卫生挑战.
- Ursodeoxycholic 酸 (UDCA) 是一种天然存在的胆汁酸,用于治疗肝脏疾病.
- UDCA对炎症,血压和肥胖的潜在影响需要研究.
研究的目的:
- 系统地审查和元分析UDCA对关键健康标志物的影响.
- 评估UDCA对体重指数 (BMI),血压 (BP) 和炎症标志物的影响.
- 综合当前关于UDCA在管理代谢和心血管风险因素中的作用的证据.
主要方法:
- 截至2024年8月,对五个主要数据库进行了全面搜索.
- 包括的研究分析了诸如BMI,静缩血压 (SBP),静缩血压 (DBP),IL-6和TNF-α等结果.
- 随机效应模型被用于计算 95% 置信区间 (CI) 的聚合加权平均差异 (WMD).
主要成果:
- UDCA的摄入量显著降低了BMI (WMD: -0.29 kg/m2,P=0.044) 和DBP (WMD: -2.16 mmHg,P=0.005) 的水平.
- 相反,UDCA与SBP (WMD:5.50 mmHg,P<0.001) 的增加有关.
- 没有发现与减肥 (P=0.561),IL-6或TNF-α水平有显著的关联.
结论:
- 补充UDCA可能对BMI和DBP有好处,但可能会提高SBP.
- 目前的证据表明,UDCA不会影响整体体重或关键炎症标志物.
- 进一步的长期,精心设计的随机对照试验 (RCT) 是必要的,以验证这些发现.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
510
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
510
Cholesterol: Significance and Regulation
497
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
497
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371


